Site for RECOVER-NEURO: A Platform Protocol for Evaluation of Interventions for Cognitive Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Sars-cov-2
  • Age: Between 18 Year(s) - 150 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Previous suspected, probable, or confirmed SARS-CoV-2 infection.
    2. Cognitive dysfunction symptoms following a SARS-CoV-2 infection that have persisted for at least 12 weeks.
    3. Fluent in English or Spanish language.
    4. Willing and able to provide informed consent, complete the intervention, complete the intervention assessments, and return for all of the necessary follow-up visits.

You may not be eligible for this study if the following are true:

    1. Known prior diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome, not related to SARS-CoV-2 infection.
    2. Known active acute SARS-CoV-2 infection = 4 weeks from consent
    3. Current use of symptomatic therapies including prescribed or illicit stimulants, amantadine, N-methyl-D-aspartate receptor antagonists (e.g., memantine, dissociative drugs).
    4. Current use of a stimulant for treating any PASC-related symptom.
    5. Current diagnosis of alcohol and substance use disorders.
    6. Known pregnancy.
    7. Currently receiving/using intervention from another clinical trial, such as another RECOVER trial.



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.